Literature DB >> 19586496

MPO-ANCA- and IgA-positive systemic vasculitis: a possibly overlapping syndrome of microscopic polyangiitis and Henoch-Schoenlein purpura.

Takeshi Nagasaka1, Jyuria Miyamoto, Masafumi Ishibashi, Kon Ron Chen.   

Abstract

Microscopic polyangiitis (MPA) can be distinguished from Henoch-Schoenlein purpura (HSP) based on the presence of renal-pulmonary complications, myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) seropositivity and pauci-immune glomerulonephritis; these characteristics of MPA are generally not found in HSP. Here, we present a unique case with MPA and HSP overlapping syndrome. A 74-year-old man presented with a skin rash accompanied by intracranial bleeding, acute renal failure and pulmonary hemorrhage resulting in a fatal outcome. An autopsy revealed the marked formation of crescentic glomerulonephritis, diffuse pulmonary alveolar hemorrhage and focal cerebral bleeding. Histological features showing both dermal small-vessel vasculitis and cutaneous polyarteritis nodosa-like arteritis suggested MPA rather than HSP, in which the dermal small vessels are exclusively affected. Meanwhile, capillary immunoglobulin (Ig)A deposits in the skin and glomeruli suggested HSP. As MPA and HSP overlapping syndrome characterized by the synergistic effect of MPO-ANCA and the IgA immune complex may result in a fatal outcome, aggressive immunosuppressive therapy should be initiated as early as possible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586496     DOI: 10.1111/j.1600-0560.2008.01145.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  8 in total

1.  Development of intracerebral hemorrhage in the short-term clinical course of a patient with microscopic polyangiitis without neurological symptoms at diagnosis: an autopsy case.

Authors:  Yoshia Miyawaki; Takayuki Katsuyama; Ken-Ei Sada; Kohei Taniguchi; Yuki Kakio; Jun Wada
Journal:  CEN Case Rep       Date:  2016-04-05

2.  Clinical significance of ANCA positivity in patients with IgA vasculitis: a retrospective monocentric study.

Authors:  Jae Yeon Kim; Hyeok Choi; Minyoung Kevin Kim; Soo Bin Lee; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2019-08-01       Impact factor: 2.631

3.  No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up.

Authors:  Izabela Grabska-Kobylecka; Dariusz Nowak; Anna Wlodarczyk; Piotr Bialasiewicz
Journal:  Clin Rheumatol       Date:  2016-07-27       Impact factor: 2.980

4.  Low-dose corticosteroid with mizoribine might be an effective therapy for elderly-onset ISKDC grade VI IgA vasculitis.

Authors:  Hikaru Sugimoto; Shiho Matsuno; Noriko Yamanaka; Wako Yumura; Mitsuyo Itabashi; Takashi Takei
Journal:  CEN Case Rep       Date:  2020-08-04

5.  A case of elderly-onset Crescentic Henoch-Schönlein purpura nephritis with hypocomplementemia and positive MPO-ANCA.

Authors:  Jung-Hee Yu; Kyu-Beck Lee; Jae Eun Lee; Hyang Kim; Kyungeun Kim; Ki-Seok Jang; Moon Hyang Park
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

6.  Myeloperoxidase-antineutrophil cytoplasmic antibody-negative microscopic polyangiitis with pulmonary haemorrhage and IgA nephropathy.

Authors:  Yuichiro Endo; Haruka Minato; Reiko Taki; Mayumi Kato; Satoshi Kore-Eda; Yoshiki Miyachi; Miki Tanioka
Journal:  Case Rep Dermatol       Date:  2011-02-05

7.  Pulmonary Hemorrhaging as a Fatal Complication of IgA Vasculitis.

Authors:  Seigo Miyoshi; Tomoaki Nagao; Masayoshi Kukida; Ken-Ichi Miyoshi; Chika Namba; Sohei Kitazawa; Yukihiro Nakamura; Naohiko Hamaguchi; Jitsuo Higaki
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

8.  A case of IgA vasculitis with necrotizing arteritis in a 13-year-old girl.

Authors:  Emi Yanai; Shingo Yamanishi; Toru Igarashi; Yujiro Tanabe; Takeshi Yanagihara; Yoko Matano; Nobuko Mayumi; Hidehisa Saeki; Motoshi Hattori; Yuri Nawashiro; Akira Shimizu; Yasuhiko Itoh
Journal:  CEN Case Rep       Date:  2021-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.